Exchange Traded Concepts LLC raised its position in shares of Dynavax Technologies Corporation (NASDAQ: DVAX) by 50.4% during the third quarter, according to its most recent disclosure with the Securi
US stock futures slightly lower. Stocks to watch: NVIDIA, Dynavax, Sobr Safe, Davis Commodities, Biohaven.
Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.

Why Dynavax Stock Soared Today

03:35pm, Wednesday, 24'th Dec 2025
Sanofi is launching an all-cash tender offer for Dynavax's shares. The French pharma giant's bid comes at a sizable premium to Dynavax's recent closing price.
Sanofi (SNY) has announced an agreement to acquire Dynavax (DVAX) for $15.50 per share, valuing the deal at approximately $2.2 billion. This acquisition will en

Dynavax Technologies Stock Soars on Buyout Buzz

11:55am, Wednesday, 24'th Dec 2025
Biotech stock Dynavax Technologies Corp (NASDAQ:DVAX) is soaring today, last seen up 38.7% at $15.43, after reports that Sanofi (SNY) plans to acquire the company in an all-cash deal worth roughly $2
MILWAUKEE , Dec. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Dynavax (Nasdaq: DVAX) for possible breaches of fiduciary duty and other violations of law in its recently announced transacti
Shares of Dynavax Technologies (DVAX) skyrocketed after French drugmaker Sanofi (SNY) said it would buy the biopharmaceutical firm for $2.2 billion to expand its Hepatitis B offerings and enter the sh
French pharmaceutical giant Sanofi SA said on Wednesday it has agreed to acquire US-based vaccines company Dynavax Technologies Corp in a $2.2 billion deal, strengthening its presence in the adult imm

Stock Futures Stifled Ahead of Shortened Trading

09:18am, Wednesday, 24'th Dec 2025
Stock futures are muted ahead of the holiday-shortened trading day on Christmas Eve
Shares of Dynavax Technologies (DVAX) surged about 37% on early Wednesday after French drugmaker Sanofi (SNY) agreed to buy the U.S. vaccine company in a cash d
Shares of Dynavax Technologies jumped sharply in premarket trading on Wednesday after the US vaccine maker agreed to be acquired by French pharmaceutical group Sanofi in an all-cash deal valued at abo
Sanofi will buy vaccine maker Dynavax Technologies for $2.2 billion, or $15.50 a share, adding to its adult immunizations. Dynavax stock soared.
Sanofi (SNY) to acquire Dynavax Technologies (DVAX) for $15.50 per share in cash, expanding its presence in adult immunization.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Dynavax Technologies Corporation (NASDAQ: DVAX) to Sanofi for $15.50 per share in cash is
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE